Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, announces the appointment of Dr. Klaus Edvardsen as its new Chief Medical ...
Investing.com -- Shares of BioArctic AB (STO:BIOA B) climbed 4.8% following the announcement of its partner Eisai’s robust sales figures for Leqembi, which exceeded consensus estimates. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback